Comparison between Crop Life Science IPO and Mono Pharmacare IPO.
IPO Details
Crop Life Science IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Mono Pharmacare IPO is a SME Bookbuilding proposed to list at NSE SME.
Issue Size and Price
The total issue size of Crop Life Science IPO is up to ₹25.38 Cr whereas the issue size of the Mono Pharmacare IPO is up to ₹14.07 Cr. The final issue price of Crop Life Science IPO is ₹52.00 per share and of Mono Pharmacare IPO is ₹28.00 per share.
IPO Timetable
Crop Life Science IPO opens on Aug 18, 2023, while Mono Pharmacare IPO opens on Aug 28, 2023. The closing date of Crop Life Science IPO and Mono Pharmacare IPO is Aug 22, 2023, and Aug 30, 2023, respectively.
| | Crop Life Science IPO | Mono Pharmacare IPO |
|---|
| Issue Open | Aug 18, 2023 | Aug 28, 2023 |
| Issue Close | Aug 22, 2023 | Aug 30, 2023 |
| Basis Of Allotment (Tentative) | Aug 25, 2023 | Sep 04, 2023 |
| Initiation of Refunds (Tentative) | Aug 28, 2023 | Sep 05, 2023 |
| Credit of Share (Tentative) | Aug 29, 2023 | Sep 06, 2023 |
| Listing date (Tentative) | Aug 30, 2023 | Sep 07, 2023 |
Financials & KPIs
Crop Life Science IPO P/E ratio is 14.29, as compared to Mono Pharmacare IPO P/E ratio of .
Shares Offered
In the Crop Life Science IPO Retail Individual Investors (RII) are offered 24,40,000 shares while in Mono Pharmacare IPO retail investors are offered 24,40,000 shares. Qualified Institutional Buyers (QIB) are offered in Crop Life Science IPO and 5,00,000 shares in Mono Pharmacare IPO.
| | Crop Life Science IPO | Mono Pharmacare IPO |
|---|
| Market Maker Reservation | 2,60,000 shares | 2,76,000 shares |
| QIB | | 5,00,000 shares |
| NII | 24,40,000 shares | 22,60,000 shares |
| RII | 24,40,000 shares | 22,64,000 shares |
| Total | 48,80,000 shares | 50,24,000 shares |
Bids Received (Subscription)
Crop Life Science IPO subscribed 4.35x in total, whereas Mono Pharmacare IPO subscribed 13.42x.
